ASTELLAS PHARMA UNSP.ADR (YPHA) — Cash Flow Quality Index
ASTELLAS PHARMA UNSP.ADR (YPHA) has a Cash Flow Quality Index of 0.61x as of March 2025. Operating cash flow of €194.51 Billion is below net income of €319.72 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore YPHA cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
ASTELLAS PHARMA UNSP.ADR Cash Flow Quality Index (2022–2025)
Historical Cash Flow Quality Index for ASTELLAS PHARMA UNSP.ADR across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see how efficiently does ASTELLAS PHARMA UNSP.ADR generate cash.
Annual Cash Flow Quality Index for ASTELLAS PHARMA UNSP.ADR (2022–2025)
Year-by-year earnings quality comparison for ASTELLAS PHARMA UNSP.ADR.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.61x | €194.51 Billion | €319.72 Billion | ▲ +3.1% |
| 2024 | 0.59x | €172.47 Billion | €292.16 Billion | ▼ -82.2% |
| 2023 | 3.32x | €327.77 Billion | €98.71 Billion | ▲ +190.3% |
| 2022 | 1.14x | €257.44 Billion | €225.09 Billion | — |